Philippines has lifted the temporary ban on the importation of poultry and other poultry from Taiwan after global animal health authorities confirmed that the country is free of the bird flu virus. The ban has been lifted on the ...
Tags: Philippines, temporary ban, lifted, bird flu virus, Taiwan
Takeda's wholly-owned subsidiary, Takeda America Holdings and LigoCyte Pharmaceuticals have entered into a definitive agreement for Takeda to acquire LigoCyte for an upfront payment of $60m, with future contingent consideration based on the ...
Synergy Pharmaceuticals has signed an asset purchase agreement to acquire FV-100 shingles drug from Bristol-Myers Squibb Company. FV-100 is an orally available nucleoside analogue, at present being developed for the treatment of shingles, ...
Tags: Synergy Pharmaceuticals, treatment of shingles, FV-100
The Health Canada has approved a label change for Biogen Idec's Tysabri to include anti-JC virus (JCV) antibody status as a risk factor for patients with multiple sclerosis (MS). The product monograph change will help enable ...
Tags: label change, Health Canada, risk assessment
IDG News Service-Japan's space agency said Friday that sensitive information on a new long-range rocket project may have been stolen by a computer virus. The Japan Aerospace Exploration Agency,or JAXA,said it found evidence that a single ...
Tags: space agency, Virus, Space Rocket Data, Japan
GenMark Diagnostics has received 510(k) clearance from the US Food and Drug Administration (FDA) for its eSensor Respiratory Virus Panel(RVP) for use on its XT-8 system. The eSensorRVP test simultaneously detects and differentiates 14 ...
Tags: XT-8 system, FDA, clinical technology, clinical research
Evotec and Haplogen have signed a drug discovery partnership targeting viral infectious diseases. The drugs resulting from the partnership are expected to target a human protein that is vital for the spread of pathogenic viral ...
Tags: the human protein, targeting viral infectious diseases, Haplogen, Evotec
The Canadian Food Inspection Agency(CFIA)has asked pig producers to take appropriate biosecurity measures to safeguard the health of their animals and people who may come into contact with them. This move comes in response to the ...
Tags: CFIA, pig producers, biosecurity measures, H3N2
Sweden based Karolinska Institutet and Immunomedics scientists have collaborated to design and test new class of drugs that destroy the AIDS virus, HIV (Human Immunodeficiency Virus), which may also help in eliminating the virus completely. ...
Tags: Immunomedics, anti-HIV agents, virus
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Novara Therapeutics, an antiviral drug discovery company, has secured $23m in Series A financing to support the development of capsid-targeting antivirals to treat chronic hepatitis B (HBV) and HIV infections. The company's antiviral ...
Tags: antiviral drug discovery company, chronic hepatitis, HIV infections
German Cancer Research Center (DKFZ) and Genetic Immunity have joined hands to develop a DNA-based vaccine to treat Human Papilloma Virus (HPV) infection that causes cervical cancer and other cancers of the anus, penis, vulva, vagina and ...
Tags: DKFZ, DNA-based vaccine, HPV, cervical cancer, cancers
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Tags: lect drug candidates, antiviral drugs, viral infections
Novartis has commenced shipment of Fluvirin influenza vaccine for the 2012-2013 influenza season, in the US. Novartis plans to ship more than 30 million doses of the Fluvirin vaccine which has been reformulated to include two new ...
Tags: Novartis, fluvirin influenza seasonal vaccine, seasonal influenza
The International AIDS Vaccine Initiative (IAVI), GlycoMimetics (GMI), and Glycosensors and Diagnostics (G&D) have collaborated to develop a vaccine against AIDS. The project being funded by IAVI's Innovation Fund will integrate the ...
Tags: HIV vaccine, vaccine against AIDS, carbohydrate immunogens